Taking aspirin could increase odds of beating breast cancer

Posted Feb 17, 2010 by KJ Mullins
A study out from Brigham and Women's Hospital and Harvard Medical School suggests taking aspirin is linked to increased survival after being diagnosed with breast cancer.
The study also shows a possible reduction of recurrence of breast cancer.
The Journal of Clinical Oncology published an article by senior author Dr Michelle Holmes in the February 16 issue.
Holmes and her team studied the data of 4,164 women who are taking part in the Nurses' Health Study. Those in the study come from the United States. The subjects have been diagnosed with all stages of breast cancer between 1976 and 2002. The subjects were studied until June 2006 or their death.
341 subjects died of breast cancer during the study.
It was observed that those who took aspirin had a decreased risk of dying from breast cancer and that the more days that subjects took aspirin the lower their risk was. This finding did not vary when it came to the stage their cancer had been in, their menopausal status, body mass index or extrogen receptor status.
The researchers also found the same findings when it came to the risk of distant recurrence of breast cancer.
"Among women living at least 1 year after a breast cancer diagnosis, aspirin use was associated with a decreased risk of distant recurrence and breast cancer death."
The Brigham and Women's Hospital and Harvard Medical School study was an observational one and not a clinical trial. Because of that women are not recommended to use the findings as a reason to start taking aspirin.
Before starting taking aspirin on a regular basis people should contact their doctor. There is an increased risk of stomach bleeding when aspirin is taken regularly.